Baicalein is a novel TLR4-targeting therapeutics agent that inhibits TLR4/HIF-1α/VEGF signaling pathway in colorectal cancer.
Minting ChenKeying ZhongJincheng TanMingjing MengChok Mei LiuBaisen ChenChunhua HuangHoi Leong Xavier WongZhaoxiang BianTao SuHiu Yee KwanPublished in: Clinical and translational medicine (2022)